ADT With Early Salvage Radiation Benefits Aggressive Prostate Cancer Patients

A new clinical trial indicates that adding androgen deprivation therapy to salvage radiation is only beneficial for prostate cancer patients with specific disease characteristics. The findings suggest a more targeted approach to post-surgery treatment.
Why it matters
This research helps clinicians avoid unnecessary treatments, improving quality of life and resource allocation for cancer patients.
ADT With Early Salvage Radiation Benefits Aggressive Prostate Cancer Patients | Mirage News
Surgery to remove a localised prostate cancer can effectively cure that cancer. But unfortunately for men with higher-risk, localised prostate cancer, the disease can return. Radiotherapy is usually offered to patients with rising PSA levels after surgery. A new trial has tested the benefit of androgen deprivation therapy added to this radiotherapy. The results showed that only patients with specific disease features benefitted from this combined treatment.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in